Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 269

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Protein Biomarkers of Cardiovascular Disease and Mortality in the Community

Open access
Ho, Jennifer E., Lyass, Asya, Courchesne, Paul, Chen, George, Liu, Chunyu, Yin, Xiaoyan, Hwang, Shih‐Jen, Massaro, Joseph M., Larson, Martin G., Levy, Daniel · 2018 · Journal of the American Heart Association

Abstract

Background: The discovery of novel and highly predictive biomarkers of cardiovascular disease ( CVD ) has the potential to improve risk‐stratification methods and may be informative regarding biological pathways contributing to disease. Methods and Results: We used a discovery proteomic platform that targeted high‐value proteins for CVD to ascertain 85 circulating protein biomarkers in 3523 Framingham Heart Study participants (mean age, 62 years; 53% women). Using multivariable‐adjusted Cox models to account for clinical variables, we found 8 biomarkers associated with incident atherosclerotic CVD , 18 with incident heart failure, 38 with all‐cause mortality, and 35 with CVD death (false discovery rate, q<0.05 for all; P ‐value ranges, 9.8×10 −34 to 3.6×10 −2 ). Notably, a number of regulators of metabolic and adipocyte homeostasis were associated with cardiovascular events, including insulin‐like growth factor 1 ( IGF 1), insulin‐like growth factor binding protein 1 ( IGFBP 1), insulin‐like growth factor binding protein 2 ( IGFBP 2), leptin, and adipsin. In a multimarker approach that accounted for clinical factors, growth differentiation factor 15 ( GDF 15) was associated with all outcomes. In addition, N‐terminal pro‐b‐type natriuretic peptide, C‐reactive protein, and leptin were associated with incident heart failure, and C‐type lectin domain family 3 member B ( CLEC 3B; tetranectin), N‐terminal pro‐b‐type natriuretic peptide, arabinogalactan protein 1 (AGP1), soluble receptor for advanced glycation end products ( sRAGE) , peripheral myelin protein 2 ( PMP 2), uncarboxylated matrix Gla protein ( UCMGP) , kallikrein B1 (KLKB1), IGFBP 2, IGF 1, leptin receptor, and cystatin‐C were associated with all‐cause mortality in a multimarker model. Conclusions: We identified numerous protein biomarkers that predicted cardiovascular outcomes and all‐cause mortality, including biomarkers representing regulators of metabolic homeostasis and inflammatory pathways. Further studies are needed to validate our findings and define clinical utility, with the ultimate goal of improving strategies for CVD prevention.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/jaha.117.008108

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 269

Metadata

Authors
Ho, J. E., Lyass, A., Courchesne, P., Chen, G., Liu, C., Yin, X., Hwang, S., Massaro, J. M., Larson, M. G., & Levy, D.
Venue
Journal of the American Heart Association
Published
2018-07-17
Volume
7
Issue
14
ISSN
2047-9980 (ISSN-L)
OpenAlex
W2883061610
Cited by
269
References
50
FWCI
20.36
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protein Biomarkers of Cardiovascular Disease and Mortality in the Community. https://app.cochat.ai/papers/10.1161/jaha.117.008108
The paper
Ho, J. E., Lyass, A., Courchesne, P., Chen, G., Liu, C., Yin, X., Hwang, S., Massaro, J. M., Larson, M. G., & Levy, D. (2018). Protein Biomarkers of Cardiovascular Disease and Mortality in the Community. Journal of the American Heart Association. https://doi.org/10.1161/jaha.117.008108

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.